Enter Note
Done
Go to previous page in this tab
Session
Clinical
Novel Hypertension Therapeutics
calendar_today
Schedule
edit_square
Notes
editor_choice
Credits
Fri, Nov 06
N230A
1:15pm - 2:30pm (Central)
HN.AOS.01
Set Timezone
Timezone
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
PT - Pacific Time
(GMT-07:00) Arizona
MT - Mountain Time
CT - Central Time
ET - Eastern Time
(GMT-05:00) Indiana (East)
—————————–
(GMT-12:00) International Date Line West
(GMT-11:00) Midway Island
(GMT-11:00) Samoa
(GMT-08:00) Tijuana, Baja California
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-06:00) Saskatchewan
(GMT-06:00) Central America
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-05:00) Bogota
(GMT-05:00) Lima
(GMT-05:00) Rio Branco
(GMT-04:30) Caracas
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Manaus
(GMT-04:00) Santiago
(GMT-04:00) La Paz
(GMT-03:30) Newfoundland
(GMT-03:00) Georgetown
(GMT-03:00) Brasilia
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT) Dublin
(GMT) Lisbon
(GMT) London
(GMT) Monrovia
(GMT) Reykjavik
(GMT) Casablanca
(GMT+01:00) Belgrade
(GMT+01:00) Bratislava
(GMT+01:00) Budapest
(GMT+01:00) Ljubljana
(GMT+01:00) Prague
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Warsaw
(GMT+01:00) Zagreb
(GMT+01:00) Brussels
(GMT+01:00) Copenhagen
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) West Central Africa
(GMT+01:00) Amsterdam
(GMT+01:00) Berlin
(GMT+01:00) Rome
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+02:00) Minsk
(GMT+02:00) Cairo
(GMT+02:00) Helsinki
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Istanbul
(GMT+02:00) Jerusalem
(GMT+02:00) Amman
(GMT+02:00) Beirut
(GMT+02:00) Windhoek
(GMT+02:00) Harare
(GMT+02:00) Johannesburg
(GMT+03:00) Kuwait
(GMT+03:00) Riyadh
(GMT+03:00) Baghdad
(GMT+03:00) Nairobi
(GMT+03:00) Tbilisi
(GMT+03:00) Moscow
(GMT+03:00) Volgograd
(GMT+03:30) Tehran
(GMT+04:00) Muscat
(GMT+04:00) Baku
(GMT+04:00) Yerevan
(GMT+05:00) Ekaterinburg
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Calcutta
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Dhaka
(GMT+06:00) Almaty
(GMT+06:00) Novosibirsk
(GMT+06:30) Yangon (Rangoon)
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Bangkok
(GMT+07:00) Jakarta
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Urumqi
(GMT+08:00) Irkutsk
(GMT+08:00) Ulaan Bataar
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Perth
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Darwin
(GMT+09:30) Adelaide
(GMT+10:00) Canberra
(GMT+10:00) Melbourne
(GMT+10:00) Sydney
(GMT+10:00) Brisbane
(GMT+10:00) Hobart
(GMT+10:00) Vladivostok
(GMT+10:00) Guam
(GMT+10:00) Port Moresby
(GMT+11:00) Magadan
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Auckland
(GMT+13:00) Nukualofa
location_on
Route Me
William Cushman
MD
University of Tennessee Health Scie
Generic 'disconnected' Message
This session focuses on exciting new developments in the pharmacologic management of hypertension
Communities
Hypertension and Nephrology
Navigation
Clinical
Session Type
Abstract Oral Session
Onsite Viewing
Live In-Person
Polling/Q&A
Novel Hypertension Therapeutics
Presentations
Presentation
Clinical
Effects of Orforglipron on Blood Pressure: Post-Hoc Analyses from ATTAIN-1 and ATTAIN-2 Trials
1:15pm-1:25pm Nov 6 (Central)
Ellen Dennehy, Sanja Giljanovic Kis, Michael Hall, Irina Jouravskaya, Luke Laffin, Runjia Li, Bruno Linetzky, Arian Plat, Markus Schlaich, Adam Stefanski
Presentation
Clinical
Q&A
1:25pm-1:30pm Nov 6 (Central)
Presentation
Clinical
BPR-30901649, a Next-Generation Angiotensinogen siRNA, Achieves Ultra-Durable Target Silencing and Sustained Blood Pressure Reduction Through 20 Weeks in Hypertensive Non-Human Primates
1:30pm-1:40pm Nov 6 (Central)
Yu Chen, XIWEN CHENG, jiachuan duan, haoxi huang, YANG LING, Jiaqi Lu
Presentation
Clinical
Q&A
1:40pm-1:45pm Nov 6 (Central)
Presentation
Clinical
Single-Dose YKYY029, an Angiotensinogen-Targeting Small Interfering RNA, in Healthy and Mildly Hypertensive Subjects: A Phase 1 Study
1:45pm-1:55pm Nov 6 (Central)
Man Bai, Shaowei Han, Zeao Huang, Haiyan Li, Zhiping Liu, Shunan Tang, Fangfang Wang, Junbo Yang, Yuping Yuan, Yuting Zhou, Jixiang Zhu
Presentation
Clinical
Q&A
1:55pm-2:00pm Nov 6 (Central)
Presentation
Clinical
Blood Pressure Lowering Following a Single Dose of Tonlamarsen Compared with a Single Dose of Placebo: A Post-Hoc Analysis of the KARDINAL Randomized Trial
2:00pm-2:10pm Nov 6 (Central)
Gene Chen, Debbie Cohen, Yehuda Cohen, Caroline Cooper, Jay Edelberg, Jessica Kim, Luke Laffin, Wanying Li, Felix Mahfoud, Lisa Mitchell, Steven Nissen, Ashish Sarraju, Markus Schlaich, Rhian Touyz, Qiuqing Wang, Kathy Wolski
Presentation
Clinical
Q&A
2:10pm-2:15pm Nov 6 (Central)
Presentation
Clinical
Angiotensinogen-Targeting RNA Interference with Zilebesiran for Hypertension: A Systematic Review and Meta-Analysis of Randomized Trials
2:15pm-2:25pm Nov 6 (Central)
Kunal Bhatt, Jay Gohri, Prakhar Gupta, Aparna Sajja, Aniroodh Venugopalan
Presentation
Clinical
Q&A
2:25pm-2:30pm Nov 6 (Central)
